Who is sponsoring NCT03096483?

NCT03096483 is sponsored by GE Healthcare.

What drugs are being tested in NCT03096483?

Interventions in NCT03096483: OEC Elite system.

What condition does NCT03096483 study?

NCT03096483 studies Interventional Vascular Conditions.

Is NCT03096483 still recruiting?

NCT03096483 is currently terminated. Last updated 27 March 2019.

Are results published for NCT03096483?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2019-03-27 · How we verify

NCT03096483

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Evaluation of the OEC Elite Vascular Mobile Fluoroscopy System

Terminated NA Results posted Last updated 27 March 2019

What this trial tests

NA trial testing OEC Elite system in Interventional Vascular Conditions in 12 participants. Terminated before completion.

Timeline

19 June 2017

Primary endpoint
7 July 2017

7 July 2017

Quick facts

Lead sponsor	GE Healthcare
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	12
Start date	19 June 2017
Primary completion	7 July 2017
Estimated completion	7 July 2017
Sites	1 location across Canada

Drugs / interventions tested

OEC Elite system

Conditions studied

Interventional Vascular Conditions — all drugs for Interventional Vascular Conditions →

Sponsor

GE Healthcare — full company profile →

Who can join

Adults 18 to 75, any sex, with Interventional Vascular Conditions. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Imaging Guidance Adequacy Assessed by Number of Questionnaires Primary · 2 Months

Per-subject investigator report for procedure completion using the Investigational Device

Group	Value	95% CI
OEC Elite Imaging Arm	11

Number of Investigator Procedure Surveys Assessed by Survey Questionnaire Secondary · 2 months

The total number of per subject survey completion reflecting the investigator opinion of procedures completed with the investigational device

Group	Value	95% CI
OEC Elite Imaging Arm	11

Sponsor's own description

The purpose of the study is to collect survey data on the use of the OEC Elite Mobile Fluoroscopy System based on the routine clinical use of the device.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other GE Healthcare trials

Trials by the same sponsor.

NCT07472491 — A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients · Phase 2, PHASE3 · recruiting
NCT07394140 — NMT EasyFit Sensor and Cable · NA · not yet recruiting
NCT07024472 — NIBP Cuff Comparison Study · completed
NCT06835647 — Maternal Fetal Device Performance Twins · NA · recruiting
NCT06639828 — Phase 4 Paediatric Study to Evaluate Sonazoid Safety and Efficacy for Contrast-Enhanced Ultrasound Liver Imaging · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03096483 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by GE Healthcare
Last refreshed: 27 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03096483.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing